Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Achondroplasia”

47 trials

Showing 20 of 47 results

Testing effectiveness (Phase 2)Ended earlyNCT05116046
What this trial is testing

Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia

Who this might be right for
Achondroplasia
Pfizer 35
Large-scale testing (Phase 3)Looking for participantsNCT06926491
What this trial is testing

Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）

Who this might be right for
Achondroplasia
Kyowa Kirin Co., Ltd. 6
Not applicableStudy completedNCT04035811
What this trial is testing

Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)

Who this might be right for
Achondroplasia
QED Therapeutics, a BridgeBio company 271
Not applicableStudy completedNCT00001536
What this trial is testing

Issues Surrounding Prenatal Genetic Testing for Achondroplasia

Who this might be right for
AchondroplasiaDwarfism
National Human Genome Research Institute (NHGRI) 2,000
Not applicableStudy completedNCT01541306
What this trial is testing

C-Type Natriuretic Peptide and Achondroplasia

Who this might be right for
AchondroplasiaHypochondroplasia
Nemours Children's Clinic 91
Not applicableStudy completedNCT01435629
What this trial is testing

A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin

Who this might be right for
Genetic DisorderAchondroplasia
Novo Nordisk A/S 81
Large-scale testing (Phase 3)Study completedNCT06164951
What this trial is testing

Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia

Who this might be right for
Achondroplasia
QED Therapeutics, a BridgeBio company 114
Testing effectiveness (Phase 2)Study completedNCT05246033
What this trial is testing

A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of Multiple Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children With Achondroplasia

Who this might be right for
Achondroplasia
Visen Pharmaceuticals (Shanghai) Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT03583697
What this trial is testing

A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia

Who this might be right for
Achondroplasia
BioMarin Pharmaceutical 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT03989947
What this trial is testing

An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia

Who this might be right for
Achondroplasia
BioMarin Pharmaceutical 73
Not applicableUnknownNCT05603936
What this trial is testing

Adaption and Testing of the Quality of Life in Short Stature Youth (QoLISSY) Questionnaire for Parents With Children From 0-4

Who this might be right for
AchondroplasiaSmall for Gestational AgeGrowth Hormone Deficiency
Universitätsklinikum Hamburg-Eppendorf 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT02724228
What this trial is testing

Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)

Who this might be right for
Achondroplasia
BioMarin Pharmaceutical 30
Testing effectiveness (Phase 2)Looking for participantsNCT06079398
What this trial is testing

A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia

Who this might be right for
Achondroplasia
Ascendis Pharma A/S 72
Testing effectiveness (Phase 2)Ended earlyNCT06067425
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia

Who this might be right for
Osteochondrodysplasia
Sanofi 16
Not applicableLooking for participantsNCT05328050
What this trial is testing

Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)

Who this might be right for
AchondroplasiaHypochondroplasia
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 200
Post-approval studies (Phase 4)Study completedNCT05353192
What this trial is testing

Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia

Who this might be right for
Achondroplasia
Changchun GeneScience Pharmaceutical Co., Ltd. 39
Not applicableStudy completedNCT03872531
What this trial is testing

Lifetime Impact Study for Achondroplasia

Who this might be right for
Achondroplasia
BioMarin Pharmaceutical 173
Testing effectiveness (Phase 2)Study completedNCT02055157
What this trial is testing

BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia

Who this might be right for
Achondroplasia
BioMarin Pharmaceutical 35
Large-scale testing (Phase 3)Enrolling By InvitationNCT05929807
What this trial is testing

A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia

Who this might be right for
Achondroplasia
Ascendis Pharma Growth Disorders A/S 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT06433557
What this trial is testing

Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia

Who this might be right for
Achondroplasia
Ascendis Pharma Growth Disorders A/S 22
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation